Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Ruxolitinib helped a patient with alopecia areata regrow hair.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Upadacitinib effectively treats psoriasis and lichen planus together.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Baricitinib may effectively treat oral lichen planus.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Drug repurposing shows promise for treating many medical conditions.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.